
Our model is to supply innovative ingredients to leading dietary supplement brands with unique marketing claims.

GoalDelight dietary supplement brands by delivering innovative nutra technology advancements that become essential to the way we live

These advancements are done though clinical trialsOver 95 human clinical trials have been conducted in the development of Zanda’s technologies offerings

Over 95 human trials in product development

The combined portfolio R&D expenditure is well over $40 million

Our technologies are being sold in over 20 countries
